ICUI · ICU Medical, Inc.
$157.18
-0.05% last session
End-of-day data · close of 2026-09-11
Market cap
$4B
Enterprise value
$5B
Trailing P/E
132.2
Forward P/E
16.3
Dividend yield
—
Beta
0.76
Avg volume
0M
Employees
13K
Daily Change %
-0.05%
5 Days Change
-3.93%
10 Days Change
-6.91%
30 Days Change
-11.58%
60 Days Change
4.26%
Month to Day Change
-5.74%
Year to Day Change
12.85%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ICUI
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-07
Latest call per bank · past 12 months
Recent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-07 | Piper Sandler | Maintains | Overweight | $163 → $195 |
| 2026-08-07 | BTIG | Maintains | Buy | $170 → $200 |
| 2026-08-07 | Needham | Maintains | Buy | $165 → $187 |
| 2026-07-21 | Keybanc | Maintains | Overweight | $164 → $182 |
| 2026-06-15 | BTIG | Initiates | Buy | $0.00 → $170 |
| 2026-05-27 | Needham | Upgrade | Hold → Buy | $0.00 → $165 |
| 2026-04-27 | Keybanc | Maintains | Overweight | $180 → $164 |
| 2026-04-17 | Piper Sandler | Maintains | Overweight | $178 → $163 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 30 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 6.5% below the 50-day MA ($168.12).
- Price vs 200-day MA: Trading 7.6% above the 200-day MA ($146.06).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-3.04) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($114.13) and high ($187.26).
ICUI Price Chart
Loading chart for ICUI…
Fundamentals
About ICU Medical, Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$129B -37.6% YTD
BDX
Becton, Dickinson and Company
$48B 20.1% YTD
MDLN
Medline Inc.
$44B -18.9% YTD
ALC
Alcon Inc.
$32B -12.8% YTD
RMD
ResMed Inc.
$32B -7.9% YTD
WST
West Pharmaceutical Services, I
$24B 22.8% YTD
SOLV
Solventum Corporation
$15B 13.6% YTD
BAX
Baxter International Inc.
$13B 27.8% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.